NCT02823353View on ClinicalTrials.gov

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

April 8, 2016

Primary Completion Date

May 6, 2022

Study Completion Date

June 30, 2022

Conditions
Primary Biliary Cirrhosis
Interventions
DRUG

Fenofibrate

Fenofibrate 200mg/day

DRUG

UDCA

UDCA 13-15mg/kg/day

Trial Locations (1)

710032

Xijing Hosipital, Xi'an

All Listed Sponsors
lead

Xijing Hospital of Digestive Diseases

OTHER

NCT02823353 - Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis | Biotech Hunter | Biotech Hunter